Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;109:1440
doi: 10.1161/01.CIR.0000120558.41356.E6
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Paolicchi, A.
Right arrow Articles by Pompella, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Paolicchi, A.
Right arrow Articles by Pompella, A.
Related Collections
Right arrow Risk Factors
Right arrow Chronic ischemic heart disease
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors

(Circulation. 2004;109:1440.)
© 2004 American Heart Association, Inc.


Images in Cardiovascular Medicine

Human Atherosclerotic Plaques Contain Gamma-Glutamyl Transpeptidase Enzyme Activity

Aldo Paolicchi, MD; Michele Emdin, MD; Erri Ghliozeni, MD; Eugenio Ciancia, MD; Claudio Passino, MD; George Popoff, MD; Alfonso Pompella, MD

From the Department of Experimental Pathology, University of Pisa, Pisa (A. Paolicchi, A. Pompella); the Institute of Clinical Physiology, National Research Council, Pisa (M.E., C.P.); Azienda Ospedaliera Pisana, Pisa (E.C.); and Clinica Villa Maria Beatrice, Firenze (E.G., G.P.), Italy.

Correspondence to Prof Aldo Paolicchi, Dipartimento di Patologia Sperimentale, sez. di Patologia Generale, Scuola Medica, via Roma, 55 I-56126, Pisa, Italy. E-mail paolicchi@biomed.unipi.it


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

During the last decade, growing evidence has shown that serum gamma-glutamyl transpeptidase (GGT) is an independent prognostic marker for cardiac death and reinfarction, both in unselected populations and in patients with coronary artery disease. Clinical and epidemiological evidence indicates that the prognostic value of GGT is largely independent of other risk factors for cardiovascular disease and alcohol consumption. The catalytic activity of GGT, which is present on the surface of cell membranes and in serum, is responsible for the extracellular catabolism of the antioxidant glutathione. Cysteinyl glycine deriving from the hydrolysis of glutathione performed by GGT has been found to trigger iron-dependent production of reactive oxygen species as well as low-density lipoprotein oxidation in vitro. The localization of GGT within the coronary plaque (Figure) provides a pathological basis for the hypothesis of a direct participation of GGT in low-density lipoprotein oxidation within the plaque and in atherogenesis and coronary artery disease progression.


Figure Removed (Available Only in the Full Text)
View larger version (179K):
[in this window]
[in a new window]
 
Histochemical and immunohistochemical demonstration of GGT enzyme activity within a frozen section of coronary atheroma from endo-arteriectomy in vivo. Histochemical reaction for GGT enzyme activity was performed by using the specific substrate gamma-glutamyl-4-methoxy-2-naphtylamide and the diazonium salt Fast Garnet GBC as a chromogen. A strong GGT activity (the red stain) is selectively present in correspondence of the core of the atheroma, while the fibrous cap stains negative (A, magnification 20x). The identification of the enzyme was confirmed immunohistochemically using a polyclonal antibody directed against the heavy chain of human GGT, which marked the same . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Circ Heart FailHome page
G. Poelzl, C. Eberl, H. Achrainer, J. Doerler, O. Pachinger, M. Frick, and H. Ulmer
Prevalence and Prognostic Significance of Elevated {gamma}-Glutamyltransferase in Chronic Heart Failure
Circ Heart Fail, July 1, 2009; 2(4): 294 - 302.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Giral, N. Jacob, C. Dourmap, B. Hansel, A. Carrie, E. Bruckert, X. Girerd, and M. J. Chapman
Elevated Gamma-Glutamyltransferase Activity and Perturbed Thiol Profile Are Associated With Features of Metabolic Syndrome
Arterioscler Thromb Vasc Biol, March 1, 2008; 28(3): 587 - 593.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
L. Kazemi-Shirazi, G. Endler, S. Winkler, T. Schickbauer, O. Wagner, and C. Marsik
Gamma Glutamyltransferase and Long-Term Survival: Is It Just the Liver?
Clin. Chem., May 1, 2007; 53(5): 940 - 946.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. M. Grundy
Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 4 - 7.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
D. S. Lee, J. C. Evans, S. J. Robins, P. W. Wilson, I. Albano, C. S. Fox, T. J. Wang, E. J. Benjamin, R. B. D'Agostino, and R. S. Vasan
Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study
Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 127 - 133.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
M. Emdin, C. Passino, A. Pompella, and A. Paolicchi
Gamma-glutamyltransferase as a cardiovascular risk factor
Eur. Heart J., September 2, 2006; 27(18): 2145 - 2146.
[Full Text] [PDF]


Home page
CirculationHome page
M. Emdin, A. Pompella, and A. Paolicchi
Gamma-Glutamyltransferase, Atherosclerosis, and Cardiovascular Disease: Triggering Oxidative Stress Within the Plaque
Circulation, October 4, 2005; 112(14): 2078 - 2080.
[Full Text] [PDF]


Home page
CirculationHome page
E. Ruttmann, L. J. Brant, H. Concin, G. Diem, K. Rapp, H. Ulmer, and the Vorarlberg Health Monitoring and Promotion Pro
{gamma}-Glutamyltransferase as a Risk Factor for Cardiovascular Disease Mortality: An Epidemiological Investigation in a Cohort of 163 944 Austrian Adults
Circulation, October 4, 2005; 112(14): 2130 - 2137.
[Abstract] [Full Text] [PDF]